Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay
- 1 January 1992
- journal article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 12 (1), 11-17
- https://doi.org/10.1002/tcm.1770120103
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Micronucleus formation by benzene, cyclophosphamide, benzo(a)pyrene, and benzidine in male, female, pregnant female, and fetal miceTeratogenesis, Carcinogenesis, and Mutagenesis, 1989
- Beneficial effects of ascorbic acid on preimplantation mouse embryos after exposure to cyclophosphamide in vivoTeratogenesis, Carcinogenesis, and Mutagenesis, 1989
- Suppression of mitomycin C-induced micronuclei in mouse bone marrow cells by post-treatment with vanillinMutation Research, 1988
- γ-l-Glutamyl-taurine (Litoralon®) prevents the micronucleus formation induced by mitomycin CMutation Research Letters, 1988
- The action of anticlastogens in human lymphocyte cultures and their modification by rat-liver S9 mixII. Studies with vitamins C and EMutation Research, 1985
- Effects of vitamins A, C, and E on aflatoxin B1-induced mutagenesis inSalmonella typhimurium TA-98 and TA-100Teratogenesis, Carcinogenesis, and Mutagenesis, 1985
- Effect of increased intake of vitamin C on the mutagenic activity of gastric juice and intragastric concentrations of ascorbic acidCarcinogenesis: Integrative Cancer Research, 1985
- Studies on the antimutagenic activity of ascorbic acid in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 1985
- Factors modulating the formation of DNA adduct by aflatoxin B1 in vitroCarcinogenesis: Integrative Cancer Research, 1984
- Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivativesMutation Research, 1982